Docetaxel Targets Aggressive Methylation Profiles and Serves as a Radiosensitizer in High-Risk Meningiomas.
Mark W YoungbloodAnh N TranWenxia WangShejuan AnDenise ScholtensLyndsee ZhangKaitlyn O'SheaJenny L PokornyStephen T MagillSean SachdevRimas V LukasAtique U AhmedDusten UnruhJordain WalshonKathleen McCortneyYufen WangAneta BaranFelix SahmKenneth D AldapeJames P ChandlerC David JamesAmy B HeimbergerCraig M HorbinskiPublished in: Neuro-oncology (2022)
Global patterns of DNA methylation may be informative for the selection of chemotherapies against meningiomas, and existing drugs may enhance radiation sensitivity in high-risk cases.